Home > Journals > Otorhinolaryngology > Past Issues > Articles online first > Otorhinolaryngology 2022 Jun 01

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

Review Article   

Otorhinolaryngology 2022 Jun 01

DOI: 10.23736/S2724-6302.22.02444-6

Copyright © 2022 EDIZIONI MINERVA MEDICA

language: English

Ear microbiome: future insights for external and middle ear diseases?

Andrea CIORBA 1 , Alberto CARANTI 1, Virginia CORAZZI 1, Chiara BIANCHINI 1, Stefano PELUCCHI 1, Elisabetta GENOVESE 2

1 ENT Department, University Hospital of Ferrara, Ferrara, Italy; 2 Audiology, Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy


PDF


INTRODUCTION: The term microbiome has been coined in 2001 to indicate microorganisms colonizing the human body. Most of these germs are symbiotic and only a few are pathogenetic and potentially harmful. In the present study, evidence in literature about the role of ear microbiome in the external and middle ear diseases has been reviewed.
METHODS: A literature search through English-language studies about “microbiome”, “external ear”, and “middle ear” has been performed. Seven relevant peer-reviewed studies, published in the last 10 years, met the inclusion criteria.
RESULTS: Recent acquisitions by Next Generation DNA Sequencing showed that Turicella otitidis, Alloiococcus otitidis, and Staphylococcus auricularis may play a significant role in the pathogenesis of childhood acute otitis media, while S. auricularis, Staphylococcus capitis/caprae, Corynebacterium otitidis, and A. otitidis are involved in external ear infections. Several microbes have been identified also in adults’ middle and external ear acute and chronic infections: Cutibacterium acnes and S. capitis/caprae, and numerous fungi species (such as Aspergillus sp., Candida albicans, etc.) in otitis media; Proteus spp, Escherichia Coli, Acetinobacter, Clostridium difficile, and Corynebacterium striatum in malignant external otitis, as well as some fungi (such as Candida Albicans, Candida Glabrata, Aspergillus spp, etc.). Acidovorax sp., Actinomycetales, and other bacteria have also been detected in the middle ear of patients suffering from cholesteatoma.
CONCLUSIONS: The evidence in literature about ear microbiome has been increasing in the recent years, allowing a better comprehension of the pathogenesis of external and middle ear diseases. These findings could possibly offer novel therapeutic insights in a near future.


KEY WORDS: Microbiome; Middle ear; External ear

top of page